ACHILLES THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.76 USD | -1.86% |
|
-2.93% | -14.51% |
Chart calendar Achilles Therapeutics plc
8122a6a4bbc51d49d8b6450086703.fIECyY998RCw3R1sLiP6_vsXQeXVhW2BCT8dEHTcd2Y.Uc9Fkc0amX7XjS05ZkWez85dcbyf_BfteGYle0O4PDAJsE2RuTKWYYGwVA~c2d79d054a7e2efefe5a2b503dc0ffe7
Upcoming events on Achilles Therapeutics plc
Past events on Achilles Therapeutics plc
| Today | Chardan Cell Therapy Manufacturing Summit |
| Today | LSX World Congress |
| 22/04/2024 | Europe ImmunoOncology Summit |
| 04/04/2024 11:45 | Q4 2023 Earnings Release |
| 29/02/2024 15:30 | Immuno Oncology 360 Conference |
| 13/11/2023 21:30 | Q3 2023 Earnings Release |
| 01/10/2023 | TIL Therapies Summit |
| 05/09/2023 | Advanced Therapies Europe Conference |
| 07/08/2023 21:15 | Immuno-Oncology Summit |
| 04/08/2023 12:00 | Q2 2023 Earnings Release |
| 28/06/2023 17:00 | Annual General Meeting |
| 21/06/2023 16:10 | Immuno-Oncology Europe Summit |
| 20/06/2023 11:00 | SAE Cell and Gene Therapy Conference |
| 10/05/2023 12:15 | Q1 2023 Earnings Release |
| 02/05/2023 | LSX World Congress |
| 24/04/2023 16:30 | Chardan Genetic Medicines and Cell Therapy Manufacturing Summit |
| 28/03/2023 | European Lung Cancer Congress |
| 19/03/2023 | BIO Europe Spring |
| 14/03/2023 12:00 | Oppenheimer Healthcare Conference |
| 09/03/2023 13:40 | EQT Life Sciences Bio Capital Europe Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -60,9 -62,2 2% | -74,7 -72,5 -3.02% | -70,5 -71,7 1.55% | -86,7 |
|
EBIT Million USD | Released Forecast Spread | -33,7 | -64,2 -64,4 0.27% | -78,4 -74,8 -4.79% | -75,3 -76,2 1.22% | -85,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -61,1 -61,0 -0.02% | -71,1 -64,1 -10.78% | -69,2 -72,0 3.99% | -80,0 |
|
Net income Million USD | Released Forecast Spread | -33,2 | -61,1 -61,5 0.6% | -71,2 -64,2 -10.84% | -69,7 -72,0 3.29% | -80,0 |
|
EPS USD | Released Forecast Spread | 0,00 | -2,13 -4,30 50.43% | -1,82 -1,67 -8.82% | -1,74 -1,38 -26.55% | -1,06 |
| Announcement Date | 25/03/21 | 01/03/22 | 07/03/23 | 04/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,5 -18,7 1.23% | -19,0 -20,6 7.82% | -20,5 -21,1 2.62% | -16,0 -22,7 29.25% | -22,8 -19,3 -18.59% | -18,6 -20,4 9.11% | -18,1 -20,7 12.53% | -19,1 -19,9 4.16% | -19,5 -20,4 4.55% | -20,5 | -21,1 | -21,8 | -22,6 | -22,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,2 -18,2 -0.39% | -17,3 -21,1 17.86% | -17,3 -21,1 18.19% | -12,4 -22,5 44.84% | -24,0 -17,1 -40.46% | -17,5 -19,8 11.77% | -16,9 -21,0 19.62% | -16,7 -20,5 18.5% | -18,1 -21,0 13.69% | -20,0 | -20,0 | -20,0 | -20,0 | -22,0 |
|
Net income Million USD | Released Forecast Spread | -18,2 -18,6 2.12% | -17,4 -20,4 14.84% | -17,3 -20,9 17.27% | -12,5 -22,5 44.66% | -24,1 -17,1 -40.7% | -17,5 -19,8 11.55% | -16,8 -21,0 19.78% | -16,7 -20,5 18.62% | -18,6 -21,0 11.29% | -20,0 | -20,0 | -20,0 | -20,0 | -22,0 |
|
EPS USD | Released Forecast Spread | -0,45 -0,76 40.79% | -0,45 -0,51 12.5% | -0,44 -0,57 22.95% | -0,32 -0,65 50.54% | -0,61 -0,22 -174.16% | -0,44 -0,49 9.28% | -0,42 -0,40 -5% | -0,42 -0,40 -5% | -0,46 -0,15 -217.24% | -0,48 | -0,49 | -0,49 | -0,36 | -0,52 |
| Announcement Date | 01/03/22 | 10/05/22 | 09/08/22 | 08/11/22 | 07/03/23 | 10/05/23 | 04/08/23 | 13/11/23 | 04/04/24 | - | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Achilles Therapeutics plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACHL Stock
- Calendar Achilles Therapeutics plc
